Luke Sergott
Stock Analyst at Barclays
Total Price Targets
60
Stocks Covered
22
Sectors
Consumer Defensive, Healthcare
Most Recent
Apr 14, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Luke Sergott
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| GH | Guardant Health, Inc. | $115.00 | $87.52 | +31.4% | 1 | Apr 14, 2026 |
| TWST | Twist Bioscience Corporation | $55.00 | $60.67 | -9.3% | 4 | Apr 14, 2026 |
| RVTY | Revvity, Inc. | $95.00 | $86.76 | +9.5% | 3 | Apr 14, 2026 |
| RGEN | Repligen Corporation | $145.00 | $117.49 | +23.4% | 2 | Apr 14, 2026 |
| CRL | Charles River Laboratories International, Inc. | $210.00 | $165.56 | +26.8% | 5 | Apr 14, 2026 |
| A | Agilent Technologies, Inc. | $140.00 | $114.72 | +22.0% | 2 | Apr 14, 2026 |
| MEDP | Medpace Holdings, Inc. | $500.00 | $417.74 | +19.7% | 2 | Mar 6, 2026 |
| WST | West Pharmaceutical Services, Inc. | $265.00 | $300.25 | -11.7% | 2 | Feb 13, 2026 |
| BRKR | Bruker Corporation | $50.00 | $36.66 | +36.4% | 2 | Feb 13, 2026 |
| IQV | IQVIA Holdings Inc. | $210.00 | $156.85 | +33.9% | 4 | Feb 6, 2026 |
| ICLR | ICON Public Limited Company | $200.00 | $112.39 | +78.0% | 3 | Dec 15, 2025 |
| FTRE | Fortrea Holdings Inc. | $15.00 | $12.02 | +24.8% | 3 | Dec 15, 2025 |
| ILMN | Illumina, Inc. | $100.00 | $134.56 | -25.7% | 6 | Oct 31, 2025 |
| AVTR | Avantor, Inc. | $12.00 | $7.97 | +50.5% | 4 | Oct 30, 2025 |
| TMO | Thermo Fisher Scientific Inc. | $585.00 | $469.31 | +24.7% | 5 | Oct 2, 2025 |
| PACB | Pacific Biosciences of California, Inc. | $1.50 | $1.59 | -6.0% | 2 | Jun 25, 2025 |
| LH | Labcorp Holdings Inc. | $271.00 | $256.56 | +5.6% | 1 | Feb 3, 2025 |
| SHC | Sotera Health Company | $17.00 | $15.64 | +8.7% | 3 | Aug 6, 2024 |
| WAT | Waters Corporation | $300.00 | $306.16 | -2.0% | 1 | Aug 1, 2024 |
| TXG | 10x Genomics, Inc. | $24.00 | $22.36 | +7.3% | 3 | Jun 28, 2024 |
| CERT | Certara, Inc. | $16.00 | $6.23 | +156.8% | 1 | Jun 28, 2024 |
| WMT | Walmart Inc. | $54.95 | $131.64 | -58.3% | 1 | Nov 16, 2022 |
Recent Activity
- Apr 14, 2026— Set$145.00price target onRGEN(Repligen Corporation)
- Apr 14, 2026— Set$95.00price target onRVTY(Revvity, Inc.)
- Apr 14, 2026— Set$115.00price target onGH(Guardant Health, Inc.)
- Apr 14, 2026— Set$210.00price target onCRL(Charles River Laboratories International, Inc.)
- Apr 14, 2026— Set$55.00price target onTWST(Twist Bioscience Corporation)
- Apr 14, 2026— Set$140.00price target onA(Agilent Technologies, Inc.)
- Mar 6, 2026— Set$500.00price target onMEDP(Medpace Holdings, Inc.)
- Feb 19, 2026— Set$200.00price target onCRL(Charles River Laboratories International, Inc.)
- Feb 13, 2026— Set$50.00price target onBRKR(Bruker Corporation)
- Feb 13, 2026— Set$265.00price target onWST(West Pharmaceutical Services, Inc.)
- Feb 6, 2026— Set$210.00price target onIQV(IQVIA Holdings Inc.)
- Dec 15, 2025— Set$115.00price target onRVTY(Revvity, Inc.)
- Dec 15, 2025— Set$200.00price target onICLR(ICON Public Limited Company)
- Dec 15, 2025— Set$15.00price target onFTRE(Fortrea Holdings Inc.)
- Dec 15, 2025— Set$525.00price target onMEDP(Medpace Holdings, Inc.)
- Oct 31, 2025— Set$100.00price target onILMN(Illumina, Inc.)
- Oct 30, 2025— Set$12.00price target onAVTR(Avantor, Inc.)
- Oct 2, 2025— Set$195.00price target onCRL(Charles River Laboratories International, Inc.)
- Oct 2, 2025— Set$200.00price target onIQV(IQVIA Holdings Inc.)
- Oct 2, 2025— Set$190.00price target onICLR(ICON Public Limited Company)
Frequently Asked Questions
Who is Luke Sergott?
Luke Sergott is a stock analyst at Barclays covering 22 stocks primarily in Consumer Defensive, Healthcare. They have issued 60 price targets since Jan 11, 2022.
What stocks does Luke Sergott cover?
Luke Sergott currently covers 22 stocks, including ILMN, CRL, TMO, TWST, IQV.
What is Luke Sergott's latest price target?
Luke Sergott's most recent price target was $145.00 on RGEN (Repligen Corporation), set on Apr 14, 2026.
What is Luke Sergott's highest price target?
Luke Sergott's highest issued price target is $685.00 on TMO, set on Aug 4, 2022.
More Analysts at Barclays
Coverage based on publicly published price targets. Not investment advice.